Verrica Pharmaceuticals Inc. conducted its first quarter 2026 earnings conference call on May 12.
The call began at 4:30 PM EDT with an operator welcoming participants and reminding listeners that the session was being recorded. Company executives including President and Chief Executive Officer Jayson Rieger, Interim Chief Financial Officer John Kirby, Chief Commercial Officer Chris Chapman, Chief Medical Officer Noah Rosenberg, and Chief Operating Officer David Zawitz joined the discussion. Analysts from firms such as LifeSci Advisors, TD Cowen, Jefferies, and Needham participated in the event.